DE60132339D1 - Verbindungen in form homodimerer oder heterodimerer prodrugs; verfahren zur herstellung dieser prodrugs und deren pharmakologisch verträglichen salzen und verwendung von verbindungen in der behandlung von phosphodiesterase vermittelten krankheiten und funktionsstörungen - Google Patents

Verbindungen in form homodimerer oder heterodimerer prodrugs; verfahren zur herstellung dieser prodrugs und deren pharmakologisch verträglichen salzen und verwendung von verbindungen in der behandlung von phosphodiesterase vermittelten krankheiten und funktionsstörungen

Info

Publication number
DE60132339D1
DE60132339D1 DE60132339T DE60132339T DE60132339D1 DE 60132339 D1 DE60132339 D1 DE 60132339D1 DE 60132339 T DE60132339 T DE 60132339T DE 60132339 T DE60132339 T DE 60132339T DE 60132339 D1 DE60132339 D1 DE 60132339D1
Authority
DE
Germany
Prior art keywords
sub
prodrugs
heterodimer
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132339T
Other languages
English (en)
Other versions
DE60132339T2 (de
Inventor
Elisa Mannochio De Russo
Valter Freire Russo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cristalia Produtos Quimicos e Farmaceuticos Ltda
Original Assignee
Cristalia Produtos Quimicos e Farmaceuticos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristalia Produtos Quimicos e Farmaceuticos Ltda filed Critical Cristalia Produtos Quimicos e Farmaceuticos Ltda
Application granted granted Critical
Publication of DE60132339D1 publication Critical patent/DE60132339D1/de
Publication of DE60132339T2 publication Critical patent/DE60132339T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60132339T 2000-08-08 2001-08-07 Verbindungen in form homodimerer oder heterodimerer prodrugs; verfahren zur herstellung dieser prodrugs und deren pharmakologisch verträglichen salzen und verwendung von verbindungen in der behandlung von phosphodiesterase vermittelten krankheiten und funktionsstörungen Expired - Lifetime DE60132339T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR0033863 2000-08-08
BRPI0003386A BRPI0003386B8 (pt) 2000-08-08 2000-08-08 pró-droga homo ou heterodiméricas úteis no tratamento de doenças ou disfunções mediadas por fosfodiesterases; composições farmacêuticas contendo a pró-droga ou seus sais farmacêuticos aceitáveis; processo de obtenção destas pró-drogas
PCT/BR2001/000096 WO2002012241A1 (en) 2000-08-08 2001-08-07 Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction

Publications (2)

Publication Number Publication Date
DE60132339D1 true DE60132339D1 (de) 2008-02-21
DE60132339T2 DE60132339T2 (de) 2008-12-24

Family

ID=3944849

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132339T Expired - Lifetime DE60132339T2 (de) 2000-08-08 2001-08-07 Verbindungen in form homodimerer oder heterodimerer prodrugs; verfahren zur herstellung dieser prodrugs und deren pharmakologisch verträglichen salzen und verwendung von verbindungen in der behandlung von phosphodiesterase vermittelten krankheiten und funktionsstörungen

Country Status (10)

Country Link
US (1) US7148350B2 (de)
EP (1) EP1315729B1 (de)
AT (1) ATE383363T1 (de)
AU (1) AU2001276200A1 (de)
BR (1) BRPI0003386B8 (de)
DE (1) DE60132339T2 (de)
DK (1) DK1315729T3 (de)
ES (1) ES2299497T3 (de)
HK (1) HK1058189A1 (de)
WO (1) WO2002012241A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008535928A (ja) * 2005-04-12 2008-09-04 シヴィダ・インコーポレイテッド ＨＭＧＣｏＡ還元酵素インヒビターの組合せ及びその使用
EP1909848A2 (de) * 2005-08-01 2008-04-16 PSivida Inc. Hmgcoa-reduktase-inhibitor-angiotensin zur umwandlung von enzym-inhibitor-verbindungen
JP2009184981A (ja) * 2008-02-07 2009-08-20 Shiseido Co Ltd 抗ｄ−アミノ酸モノクローナル抗体及び、抗ｄ−アミノ酸モノクローナル抗体を用いたｄ−アミノ酸の免疫学的分析方法
WO2015093924A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Issac Vehículo para la administración de compuestos farmacéuticos
CN109658984B (zh) * 2018-12-18 2021-12-03 北京深度制耀科技有限公司 一种信息推荐和信息推荐模型训练方法、相关装置

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4631190A (en) * 1981-06-26 1986-12-23 Shen Wei C Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers
US4997913A (en) * 1986-06-30 1991-03-05 Oncogen pH-sensitive immunoconjugates and methods for their use in tumor therapy
US4863911A (en) * 1986-08-04 1989-09-05 University Of Florida Method for treating male sexual dysfunction
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5140013A (en) * 1989-11-28 1992-08-18 Universite Laval Maleic anhydride derivatives used as conjugation agents of anti-tumor agents on desired carriers
FI101678B1 (fi) * 1990-12-31 1998-08-14 Akzo Nv Happolabiileja kytkentämolekyylejä
SE9103701D0 (sv) * 1991-12-13 1991-12-13 Kabi Pharmacia Ab Apolipoprotein
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
DE69508255T2 (de) * 1994-07-15 1999-10-14 Biosearch Italia S.P.A. Dinukleosid-5',5'- pyrophosphate
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6031096A (en) * 1997-05-15 2000-02-29 Drug Innovation & Design, Inc. Acyclovir diester derivatives
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6030997A (en) * 1998-01-21 2000-02-29 Eilat; Eran Acid labile prodrugs
AU4068599A (en) 1998-05-20 1999-12-06 Schering Corporation Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
US6124461A (en) 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
US6288234B1 (en) * 1998-06-08 2001-09-11 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
US6265420B1 (en) 1998-06-23 2001-07-24 Medinox, Inc. Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
AU4717299A (en) 1998-06-26 2000-01-17 Nastech Pharmaceutical Company, Inc Nasal delivery of sildenafil citrate
DE19834506A1 (de) 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
DE19834505A1 (de) 1998-07-31 2000-02-03 Hexal Ag Transdermales therapeutisches System zur Anwendung von Sildenafil

Also Published As

Publication number Publication date
ATE383363T1 (de) 2008-01-15
HK1058189A1 (en) 2004-05-07
BRPI0003386B8 (pt) 2021-05-25
BR0003386A (pt) 2004-07-06
DE60132339T2 (de) 2008-12-24
AU2001276200A1 (en) 2002-02-18
US20040106629A1 (en) 2004-06-03
ES2299497T3 (es) 2008-06-01
EP1315729A4 (de) 2004-07-07
WO2002012241A1 (en) 2002-02-14
EP1315729B1 (de) 2008-01-09
EP1315729A1 (de) 2003-06-04
BRPI0003386B1 (pt) 2016-10-11
WO2002012241A8 (en) 2003-12-04
US7148350B2 (en) 2006-12-12
DK1315729T3 (da) 2008-05-26

Similar Documents

Publication Publication Date Title
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
TR200000837A2 (tr) Anti-kanser bileşimleri hazırlamak için işlem ve ara maddeler.
BR9708261A (pt) Composto antagonista de crf, composiçãofarmacêutica, método de tratamento dedistúrbios, processo para a produção depirimidina, pirimidona, método para a produção deum composto e composto
UY25344A1 (es) Procedimiento para la preparacion de derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
PT1159279E (pt) 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
BR0116468A (pt) Compostos de pirrolina substituìda por indazolila como inibidores de cinase
IS6305A (is) Kínasólínafleiður og notkun þeirra sem lyf
UY25805A1 (es) Azalidas de 13 miembros y su uso como agentes antibióticos.
CY1112143T1 (el) Χρηση παραγωγων kykλοπenta[g]kinαζολινης για θεραπεια καρκινου
SE9904129D0 (sv) Novel compounds
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
DE60132339D1 (de) Verbindungen in form homodimerer oder heterodimerer prodrugs; verfahren zur herstellung dieser prodrugs und deren pharmakologisch verträglichen salzen und verwendung von verbindungen in der behandlung von phosphodiesterase vermittelten krankheiten und funktionsstörungen
GT200100232A (es) Derivados de pirimidina.
AR026222A1 (es) Compuestos derivados de acido antranilico
ES2051723T3 (es) Procedimiento para preparar tetrahidroaminoquinolinoles heterociclicos condensados.
DE69900297D1 (de) Akarizid und insektizid wirksame, substituierte Pyrimidine und Verfahren zu ihrer Herstellung
DE69925160D1 (de) Arylpiperidin- und aryl-1,2,5,6-tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität
BG103861A (en) 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
PT96757A (pt) Processo de preparacao de derivados de indolo e de composicoes farmaceuticas
TR200003877T2 (tr) İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri
YU244990A (sh) Aminopiridinilmetanoli in aminometilpiridinamini ter srodne spojine, kot tudi postopek za njihovo pripravo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition